We're building a better ClinicalTrials.gov. Check it out and tell us what you think!

Key Record Dates

ClinicalTrials.gov Identifier: NCT03573401
Brief Title: Study to Evaluate the Safety and Efficacy of BF-200 ALA (Ameluz®) and BF-RhodoLED® in the Treatment of Superficial Basal Cell Carcinoma (sBCC) With Photodynamic Therapy (PDT).

First Submitted : June 19, 2018
First Submitted that Met QC Criteria : June 28, 2018
First Posted : June 29, 2018

Last Update Submitted that Met QC Criteria : February 9, 2022
Last Update Posted : February 10, 2022